Holger Zimmermann
Vorstandsvorsitzender bei AiCuris GmbH & Co. KG
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Helga Rübsamen-Schaeff | M | 75 |
AiCuris GmbH & Co. KG
AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany.
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | 30 Jahre |
Stefan Oschmann | M | 66 |
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | - |
Sean Marett | M | 59 |
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | 3 Jahre |
Paul Achleitner | M | 67 | 22 Jahre | |
Manickam Rangaraju | M | - |
AiCuris GmbH & Co. KG
AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | 9 Jahre |
Holger Schmoll | M | - |
AiCuris Verwaltungs-GmbH
AiCuris Verwaltungs-GmbH Miscellaneous Commercial ServicesCommercial Services AiCuris Verwaltungs GmbH engages in the acquisition and management of participating interests in firms, whose business activities focus on research and development as well as service provision in the healthcare sector. The company was founded on September 1, 2005 and is headquartered in Wuppertal, Germany. | - |
Helmut Jeggle | M | 53 |
AiCuris GmbH & Co. KG
AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | - |
Alexander Birkmann | M | - |
AiCuris GmbH & Co. KG
AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | 18 Jahre |
Larry G. Edwards | M | 52 |
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | 1 Jahre |
Bernd Uttich | M | - |
G&Z Montageservice GmbH
G&Z Montageservice GmbH Marine ShippingTransportation G & Z Montageservice GmbH is a German company that provides contract-based services for the deployment of assembly and service personnel. The private company is based in Castrop Rauxel, Germany. The company's goal is to execute projects around the world quickly, safely, and professionally. The company specializes in industrial assembly and strive to provide excellent service and project management. The CEOs of the company are Holger Zimmermann, Bernd Uttich. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Frank Morich | M | 69 | 20 Jahre | |
Klaus-Christian Kleinfeld | M | 65 | 9 Jahre | |
Bernd Metzner | M | 53 | 4 Jahre | |
Johannes M. Dietsch | M | 62 | 16 Jahre | |
Ulrich Hauck | M | 60 | 12 Jahre | |
Rolf Hoffmann | M | 48 | - | |
William Carson | M | 76 | 8 Jahre | |
Joe W. Martin | M | 71 | 12 Jahre | |
Rainier van Roessel | M | 66 | 11 Jahre | |
Thomas Henkel | M | 62 | - | |
Bernard Mathias Becker | M | 59 | 2 Jahre | |
John-Edward Butler-Ransohoff | M | - | 10 Jahre | |
Wolfgang Plischke | M | 72 | 19 Jahre | |
Marie Paule Richard | M | 72 |
AiCuris GmbH & Co. KG
AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | 2 Jahre |
Florian Schwalbach | M | - | - | |
Christoph Petry | M | - | 13 Jahre | |
Anja Dubbert | F | 45 | 1 Jahre | |
Dariusz Adam Bak | M | 55 | 4 Jahre | |
Thomas Hoffmann | M | 53 | - | |
Irena Küstner | F | 58 | - | |
Manuela Strauch | F | 52 | - | |
Neil Gibson | M | 67 | 4 Jahre | |
Colin Foster | M | 61 | 10 Jahre | |
Vikram Lamba | M | 58 | 8 Jahre | |
Alexander Rosar | M | - | - | |
David A. Lowe | M | 77 | 5 Jahre | |
Frank Armstrong | M | 67 | 3 Jahre | |
Vikas Sinha | M | 60 | 11 Jahre | |
Paolo Pucci | M | 63 | 7 Jahre | |
Stephen W. Zaruby | M | 61 | 6 Jahre | |
Bernhard Opitz | M | 66 | 20 Jahre | |
Lodewijk Christian van Wachem | M | 92 | - | |
Knut Kleedehn | M | 86 | - | |
David Ebsworth | M | 69 | 19 Jahre | |
Kevin B. Bacon | M | 59 | 5 Jahre | |
Pol Bamelis | M | 85 | 36 Jahre | |
Jürgen Weber | M | 82 | - | |
Hoa Hong | F | - | 4 Jahre | |
Walter Wenninger | M | 86 | 6 Jahre | |
Ekkehard D. Schulz | M | 82 | 9 Jahre | |
Hans-Olaf Henkel | M | 84 | 10 Jahre | |
David M. Hillenbrand | M | 76 | - | |
Dieter Schulte | M | - | - | |
Douglas Liu | M | 62 | 9 Jahre | |
petra Molan | F | - | 3 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Deutschland | 55 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Holger Zimmermann
- Persönliches Netzwerk